| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |